Sandham, D., Chen, W., Hardman, C., Luo, J., Xue, L., Ogg, G., & Erpenbeck, V. (2019). Fevipiprant inhibits prostaglandin D2 mediated activation of group 2 innate lymphoid cells (ILC2s). Wiley.
Style de citation Chicago (17e éd.)Sandham, D., W. Chen, C. Hardman, J. Luo, L. Xue, G. Ogg, et V. Erpenbeck. Fevipiprant Inhibits Prostaglandin D2 Mediated Activation of Group 2 Innate Lymphoid Cells (ILC2s). Wiley, 2019.
Style de citation MLA (9e éd.)Sandham, D., et al. Fevipiprant Inhibits Prostaglandin D2 Mediated Activation of Group 2 Innate Lymphoid Cells (ILC2s). Wiley, 2019.
Attention : ces citations peuvent ne pas être correctes à 100%.